CMC 2023 The Canadian Musculoskeletal Conference (CMC) hosted by Osteoporosis Canada is November 23 and 24, 2023. Led by national and international experts in osteoporosis, this dynamic conference will offer […]

Tools Algorithm 1 Integrated approach to the management of bone health and fracture prevention in postmenopausal females and males 50 years and older. DOWNLOAD Algorithm 2 Approach to pharmacotherapy to […]

UNBREAKABLE The OC Podcast : Bone Health + Osteoporosis UNBREAKABLE The OC Podcast from Osteoporosis Canada features evidence-based information from healthcare providers and subject matter experts, as well as personal […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

UNBREAKABLE The OC Podcast : Bone Health + Osteoporosis UNBREAKABLE The OC Podcast from Osteoporosis Canada features evidence-based information from healthcare providers and subject matter experts, as well as personal […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

Osteoporosis is a disease that takes years to develop without any warning symptoms. Bone mass is gradually lost, making the bones weaker and more prone to fracturing or breaking. The […]

UNBREAKABLE The OC Podcast : Bone Health + Osteoporosis UNBREAKABLE The OC Podcast from Osteoporosis Canada features evidence-based information from healthcare providers and subject matter experts, as well as personal […]

UNBREAKABLE The OC Podcast : Bone Health + Osteoporosis UNBREAKABLE The OC Podcast from Osteoporosis Canada features evidence-based information from healthcare providers and subject matter experts, as well as personal […]